Effect of spironolactone on left ventricular ejection fraction and volumes in patients with class I or II heart failure.
Vizzardi
Enrico
E
Department of Cardiology, University of Brescia, Italy. enrico.vizzardi@tin.it
D'Aloia
Antonio
A
Giubbini
Raffaele
R
Bordonali
Tania
T
Bugatti
Silvia
S
Pezzali
Natalia
N
Romeo
Alessia
A
Dei Cas
Alessandra
A
Metra
Marco
M
Dei Cas
Livio
L
D000704:Analysis of Variance; D015415:Biomarkers / Q000097:blood; D015150:Echocardiography, Doppler; D005080:Exercise Test; D005260:Female; D006333:Heart Failure / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D010101:Oxygen Consumption / Q000502:physiology; D010919:Placebos; D019275:Radiopharmaceuticals; D016037:Single-Blind Method; D013148:Spironolactone / Q000627:therapeutic use*; D013318:Stroke Volume / Q000187:drug effects*; D017256:Technetium Tc 99m Sestamibi; D015899:Tomography, Emission-Computed, Single-Photon; D016896:Treatment Outcome
D015415:Biomarkers; D000451:Mineralocorticoid Receptor Antagonists; D010919:Placebos; D019275:Radiopharmaceuticals; D013148:Spironolactone; D017256:Technetium Tc 99m Sestamibi